Methods, panels, devices and kits to determine, predict or differentiate the occurrence of stroke, disease or brain damage using biomarkers (Machine-translation by Google Translate, not legally binding)

Methods, panels, devices and kits to determine, predict or differentiate the occurrence of stroke, disease or brain damage using biomarkers. The methods comprise analyzing a biological sample of nasal exudate to determine the presence or quantity of one or more biomarkers, and then correlate it with...

Full description

Saved in:
Bibliographic Details
Main Authors GARCIA-CABO FERNANDEZ, Carmen, COSTA FERNANDEZ, Jose Manuel, LLANO SUAREZ, Pablo, CALLEJA PUERTA, Sergio, FERNANDEZ ABEDUL, María Teresa, BENAVENTE FERNANDEZ, Lorena
Format Patent
LanguageEnglish
Spanish
Published 23.11.2020
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Methods, panels, devices and kits to determine, predict or differentiate the occurrence of stroke, disease or brain damage using biomarkers. The methods comprise analyzing a biological sample of nasal exudate to determine the presence or quantity of one or more biomarkers, and then correlate it with the occurrence of a cerebral event. The panels comprise a plurality of biomarkers derived from a nasal exudate sample from the subject. The devices comprise a receptacle for a nasal exudate sample, a detection means and a correlation means. The kits comprise means of detection or means of extraction of a sample that is or comprises nasal exudate from the subject. The present invention is applicable in the biotechnology and pharmacy sectors, as well as in medicine and clinical diagnostics. (Machine-translation by Google Translate, not legally binding) Métodos, paneles, dispositivos y kit para determinar, predecir o diferenciar la ocurrencia de ictus, enfermedades o daños cerebrales mediante biomarcadores. Los métodos comprenden analizar una muestra biológica de exudado nasal para determinar la presencia o la cantidad de uno o más biomarcadores, para después correlacionarla con la ocurrencia de un episodio cerebral. Los paneles comprenden una pluralidad de biomarcadores que proceden de una muestra de exudado nasal del sujeto. Los dispositivos comprenden un receptáculo para una muestra de exudado nasal, unos medios de detección y unos medios de correlación. Los kits comprenden medios de detección o medios de extracción de una muestra que es o comprende exudado nasal del sujeto. La presente invención resulta de aplicación en los sectores de la biotecnología y farmacia, así como en medicina y diagnóstico clínico.
Bibliography:Application Number: ES20190000087